> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Statin intolerance is often followed by stopping all lipid-lowering therapy
- URL: https://www.coios.me/statin-intolerance-is-often-followed-by-stopping-all-lipid/
- Published: 2026-11-03T13:08:19.000Z
- Updated: 2026-11-03T17:56:20.000Z
- Description: In a US health system, 39.9% of patients with documented statin intolerance stopped all lipid-lowering therapy within 90 days.
- Author: Daniel Ryan
- Tags: Health today, Heart and stroke, Adherence and persistence, United States, #peer-reviewed, #refines, #item, #source-2026-11, #score-68

Of 254,035 new statin users at Mass General Brigham, 10,644 (4.2%) developed clinician-documented intolerance after a median 3.1 years. Within 90 days, 39.9% stopped all lipid-lowering therapy and fewer than 10% received a nonstatin-based strategy. At 3 to 6 months, mean LDL cholesterol rose 6.8 mg/dL in discontinuers and fell 4.9 mg/dL in continuers. Against statin-tolerant patients, intolerance had hazard ratios of 1.12 to 1.55 for revascularisation, myocardial infarction and ischaemic stroke. Among intolerant patients, stopping all therapy had hazard ratios from 1.38 for death to 2.14 for venous thromboembolism. The time-varying Cox analysis is observational and from one health system, so those who stopped may differ in other ways.

*Why it is interesting: Two in five patients recorded as statin-intolerant stopped all lipid-lowering treatment within 90 days. Those who stopped had rising LDL cholesterol and higher risk of every outcome than those continuing any.*

Source

[Journal of the American Heart Association, 2 November 2026](https://doi.org/10.1161/JAHA.126.053967?ref=coios.me)

Paper

Statin Intolerance, Treatment Gaps, and Cardiovascular Outcomes: A 24-Year Health System Analysis

Authors

Supriami K, Akl EW, Abou-Karam R, Thompson AG, Yudelman M, Atlas SJ et al.

DOI

10.1161/JAHA.126.053967

Type

Peer-reviewed article

Design

Retrospective EHR cohort of 254,035 new statin users, Mass General Brigham, records 1987–2025 (trends 2001–2024), time-varying Cox models

Verdict

Refines prior evidence

Driver

[Heart and stroke](https://www.coios.me/d-cardiovascular/)

Driver

[Adherence and persistence](https://www.coios.me/d-adherence/)